SCHEMBL19690602

SCHEMBL19690602

CC(C)C1CCCCC1OC(=O)CCC(=O)O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.46
ALDH1A1 P00352 4/20 0.39
MMP3 P08254 2/20 0.38
EPHX1 P07099 2/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
CYP19A1 P11511 2/20 0.36
APOBEC3A P31941 1/20 0.35
APOBEC3G Q9HC16 1/20 0.35
SLC18A3 Q16572 1/20 0.35
NAAA Q02083 2/20 0.35
KDM6B O15054 1/20 0.34
KDM5C P41229 1/20 0.34
EGLN1 Q9GZT9 1/20 0.34
PHF8 Q9UPP1 1/20 0.34
KDM2A Q9Y2K7 1/20 0.34
MAPT P10636 2/20 0.34
TSHR P16473 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
KDM4E B2RXH2 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19690601 0.93 ALDH1A1 (0.40) LMNAALDH1A1EPHX1MEN1KMT2A
SCHEMBL27622679 0.84 ALDH1A1 (0.40) LMNAALDH1A1EPHX1MEN1KMT2A
SCHEMBL16281717 0.83 ALDH1A1 (0.35) LMNAALDH1A1EPHX1MEN1KMT2A
SCHEMBL14580755 0.80 CYP19A1 (0.56) LMNAALDH1A1EPHX1MEN1KMT2A
SCHEMBL3397280 0.80 CYP19A1 (0.56) LMNAALDH1A1EPHX1MEN1KMT2A
SCHEMBL4753036 0.80 CYP19A1 (0.56) LMNAALDH1A1EPHX1MEN1KMT2A
SCHEMBL29018706 0.80 CYP19A1 (0.56) LMNAALDH1A1EPHX1MEN1KMT2A
SCHEMBL14565716 0.80 CYP19A1 (0.56) LMNAALDH1A1EPHX1MEN1KMT2A
SCHEMBL12449331 0.80 CYP19A1 (0.56) LMNAALDH1A1EPHX1MEN1KMT2A
SCHEMBL79842 0.80 CYP19A1 (0.56) LMNAALDH1A1EPHX1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025020304-A1 CATALYST COMPONENT FOR OLEFIN POLYMERIZATION, CATALYST AND USE OF CATALYST 中国石油天然气股份有限公司 2025-01-30 WO disclosed
WO-2022078492-A1 MAGNESIUM-BASED SOLID AND CATALYST COMPONENT HAVING MULTIMODAL PORE DISTRIBUTION, AND PREPARATION METHODS THEREFOR 中国石油化工股份有限公司 2022-04-21 WO disclosed
US-20190169328-A1 OLEFIN POLYMERIZATION CATALYST CARRIER, SOLID CATALYST COMPONENT AND USE THEREOF RENQIU LIHE TECH LTD (CN) 2019-06-06 US disclosed
US-20170355792-A1 OLEFIN POLYMERIZATION CATALYST CARRIER, SOLID CATALYST COMPONENT AND USE THEREOF RENQIU LIHE TECH LTD (CN) 2017-12-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190169328-A1 OLEFIN POLYMERIZATION CATALYST CARRIER, SOLID CATALYST COMPONENT AND USE THEREOF COG2, GTF2I, POF1B LMNA 2302/4885ALDH1A1 2055/4885MMP3 4340/4885
US-20170355792-A1 OLEFIN POLYMERIZATION CATALYST CARRIER, SOLID CATALYST COMPONENT AND USE THEREOF COG2, COG7, COG4 LMNA 3701/4885ALDH1A1 2496/4885MMP3 4730/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.